Pure Global

EUROIMMUN Anti-Rubella Virus Glycoprotein ELISA (IgM) - Indonesia BPOM Medical Device Registration

EUROIMMUN Anti-Rubella Virus Glycoprotein ELISA (IgM) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303021065. The device is manufactured by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG. from Germany, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is INTI MAKMUR MEDITAMA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
EUROIMMUN Anti-Rubella Virus Glycoprotein ELISA (IgM)
Analysis ID: AKL 20303021065

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Country of Origin

Germany

Authorized Representative

INTI MAKMUR MEDITAMA

AR Address

JL. SULTAN ISKANDAR MUDA, GANDARIA 8 OFFICE TOWER LANTAI 16 UNIT F, KEBAYORAN LAMA JAKARTA SELATAN

Registration Date

Aug 19, 2024

Expiry Date

Aug 30, 2028

Product Type

Serological Reagents

Rubella virus serological reagents.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing